Jonathan Barratt

49PUBLICATIONS
148CO-AUTHORS
NaturopathyPanel data analysisImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Mar 29, 2026
Efficacy and Safety of Atrasentan in Patients with IgA Nephropathy Receiving Sodium-Glucose Cotransporter 2 Inhibitors: Placebo-Controlled, Crossover Trial.

Hiddo J L Heerspink, Irene L Noronha, Jose Luis Górriz

|Jan 26, 2026
Test accuracy of glomerular filtration rate estimation with creatinine and cystatin C in adults with moderate chronic kidney disease: prospective cohort study.

Edmund J Lamb, Jonathan Barratt, Elizabeth Ann Brettell

|Nov 24, 2025
Individualized treatment effects of corticosteroids in IgA nephropathy.

David L Hoelscher, Nikolas Ej Schmitz, Leon Niggemeier

|Dec 26, 2024
Efficacy and Safety of Nefecon in Patients with IgA Nephropathy from Mainland China: 2-Year NefIgArd Trial Results.

Hong Zhang, Richard Lafayette, Bei Wang

|Sep 27, 2024
Mucosal targeting in IgA nephropathy targeting the gut associated lymphoid tissue.

Jonathan Barratt

|Sep 04, 2024
The pathogenesis of IgA nephropathy and implications for treatment.

Chee Kay Cheung, Suceena Alexander, Heather N Reich

Pageof 9

Frequent Collaborators

6 joint publications

Richard Lafayette

5 joint publications

Chee Kay Cheung

3 joint publications

Maarten W Taal

3 joint publications

Vladimír Tesař